Cesarean section surgery
Conditions
Interventions
N1:intramyometrial injection 20IU oxytocin, iv pumping oxytocin 7.5U/h
N2:intramyometrial injiection 10IU oxytocin, iv pumping oxytocin 7.5IU/h
N3:intramyometrial injiection 10IU oxytocin
N4:iv injection 1IU oxytocin, iv pumping oxytocin 7.5IU/h
E3:intramyometrial injiection 10IU oxytocin
E1:intramyometrial injection 20IU oxytocin, iv pumping oxytocin 7.5U/h
E2:intramyometrial injiection 10IU oxytocin, iv pumping oxytocin 7.5IU/h
E4:iv injection 3IU oxytocin, iv pumping oxytocin 7.5IU/h
Sponsors
Beijing Pinggu District Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Patients over 18 years old; 2. Patients with gestation >= 37 weeks; 3. Patients with ASA grade 1-2; 4. Subjects or their legal clients voluntarily participate in this study, 5. The patients who signed the informed consent have good compliance and can cooperate with the follow-up.
Exclusion criteria
Exclusion criteria: 1. Subjects with preoperative diagnosis of placenta previa; 2. Subjects with placenta accreta; 3. Subjects with abnormal coagulation function; 4. The subjects who used oxytocin, carbetoxine, misoprostol and carboprost within 2 hours before operation; 5. Patients with previous cardiovascular diseases, perinatal cardiomyopathy, preoperative ECG serious arrhythmia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| uterus contractility;blood loss intraoperation;blood pressure;heart rate; | — |
Countries
China
Contacts
Public ContactJiahe Lin
Beijing Pinggu District Hospital
Outcome results
None listed